Table 1. Background clinical and demographic characteristics of the study participants.
| Characteristics | Attributes | Navrongo | Kintampo | Dodowa |
|---|---|---|---|---|
| Recruitment | Total (%) | 1901 (41.7) | 1778 (39.0) | 884 (19.3) |
| Nested (%) | 274 (61.7) | 15 (3.4) | 155 (34.9) | |
| Age of Participants (years) | Average (SD) | 12.6(15.4) | 7.6(9.3) | 14.7(15.6) |
| Weight of Participants (kg) | Average (SD) | 27.8(19.2) | 21.3(15.2) | 33.6(21.7) |
| Sex of participants, n (%) | Males | 908 (47.8) | 867 (48.8) | 410 (46.4) |
| Female | 993 (52.2) | 911 (51.2) | 474 (53.6) | |
| Age in years, n (%) | < 6 | 837 (44.0) | 1057 (59.5) | 307 (34.7) |
| 6–12 | 522 (27.5) | 488 (27.5) | 254 (28.7) | |
| 13- <18 | 172 (9.1) | 84 (4.7) | 113 (12.8) | |
| ≥ 18 | 370 (19.5) | 149 (8.4) | 210 (23.8) | |
| Fever (T ≥ 37.5°C), n (%) | Yes | 555 (29.2) | 721 (40.6) | 222 (25.1) |
| No | 1346 (70.8) | 1057 (59.5) | 662 (74.9) | |
| 1Parasite density/μL, n (%) | <50 | 53 (4.0) | 13 (1.0) | 24 (3.3) |
| 50–499 | 288 (21.8) | 105 (7.7) | 77 (10.5) | |
| 500–4,999 | 223 (16.9) | 206 (15.2) | 205 (27.8) | |
| 5000–49,999 | 556 (42.1) | 377 (27.6) | 183 (24.8) | |
| ≥ 50,000 | 200 (15.2) | 659 (48.5) | 248 (33.6) | |
| Ingestion of antimalarials within the last 4 weeks, n (%) | Males | 37 (4.1) | 23 (2.7) | 8 (2.0) |
| Females | 45 (4.5) | 39 (4.3) | 4 (0.8) | |
| Ingestion of any medication within the last 2 weeks, n (%) | Males | 144 (15.6) | 159 (18.3) | 131(32.0) |
| Females | 159 (16.0) | 159 (17.5) | 134 (28.2) |
1The discrepancy between the total number enrolled and the number with parasite density is that the initial diagnosis of malaria was confirmed with malaria rapid diagnostic test